Title : Predictors of long-term outcome in multiple sclerosis patients treated with interferon β.

Pub. Date : 2013 Jan

PMID : 23378325






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In the IM IFNbeta-1a group, persistent disease activity predicted severe EDSS worsening: gadolinium-enhancing lesions (odds ratio [OR], 8.96; p < 0.001); relapses (OR, 4.44; p = 0.010); and new T2 lesions (OR, 2.90; p = 0.080). Gadolinium interferon beta 1 Homo sapiens
2 Particular attention should be paid to gadolinium-enhancing lesions on IFNbeta therapy, as their presence strongly correlates with severe disability 15 years later. Gadolinium interferon beta 1 Homo sapiens